Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$19.7K Sell
12,850
-294,421
-96% -$448K ﹤0.01% 3907
2026
Q1
$556K Sell
307,271
-44,856
-13% -$77.6K 0.01% 1946
2025
Q4
$475K Sell
352,127
-103,166
-23% -$147K 0.01% 1649
2025
Q3
$742K Buy
455,293
+245,671
+117% +$272K 0.04% 777
2025
Q2
$203K Buy
+209,622
New +$174K 0.01% 1689
2025
Q1
Sell
-254,995
Closed -$205K 2891
2024
Q4
$205K Buy
254,995
+19,894
+8% +$18.2K 0.02% 1542
2024
Q3
$233K Buy
+235,101
New +$323K 0.02% 1352
2024
Q1
Sell
-24,702
Closed -$14.2K 2169
2023
Q4
$14.2K Buy
+24,702
New +$9.9K ﹤0.01% 1398
2023
Q3
Sell
-88,353
Closed -$48K 1878
2023
Q2
$48K Buy
+88,353
New +$56.7K 0.01% 1244
2022
Q3
Sell
-10,275
Closed -$23K 1303
2022
Q2
$23K Buy
+10,275
New +$24.6K 0.01% 804
2022
Q1
Sell
-13,893
Closed -$63K 880
2021
Q4
$63K Buy
+13,893
New +$105K 0.04% 535
2021
Q3
Sell
-20,744
Closed -$167K 949
2021
Q2
$167K Buy
20,744
+6,579
+46% +$55.5K 0.06% 586
2021
Q1
$96K Buy
+14,165
New +$94.2K 0.05% 571

Other funds holding OCGN

XTX Topco's OCGN Position: Q2 2026 in Review

XTX Topco reduced its Ocugen (OCGN) stake by 96% in Q2 2026, selling an estimated $448K and leaving 12,850 shares worth $19.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3907.

XTX Topco first reported a position in OCGN in Q1 2021 and has held it in 13 quarters since. The position peaked at $742K in Q3 2025. 147 funds tracked by Wall St. Rank hold OCGN as of Q2 2026.

  • XTX Topco held 12,850 shares of Ocugen worth $19.7K as of Q2 2026.
  • XTX Topco sold 294,421 Ocugen shares in Q2 2026, an estimated $448K.
  • Ocugen made up ﹤0.01% of XTX Topco's portfolio in Q2 2026, its #3907 holding.
  • XTX Topco first reported a position in Ocugen in Q1 2021 and has held it in 13 quarters since.
  • XTX Topco's Ocugen position peaked at $742K in Q3 2025.
  • 147 funds tracked by Wall St. Rank held Ocugen as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.